Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials

Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. A total of 80–90% of patients with childhood idiopathic nephrotic syndrome achieve remission with steroid therapy [steroid-sensitive nephrotic syndrome (SSNS)]. However, approximately 50% of children with SSNS d...

Descripción completa

Detalles Bibliográficos
Autores principales: Iijima, Kazumoto, Sako, Mayumi, Kamei, Koichi, Nozu, Kandai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061657/
https://www.ncbi.nlm.nih.gov/pubmed/28717938
http://dx.doi.org/10.1007/s00467-017-3746-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061657/
https://www.ncbi.nlm.nih.gov/pubmed/28717938
http://dx.doi.org/10.1007/s00467-017-3746-9

Ejemplares similares